A carregar...

Radiofrequency Ablation with Continued EGFR Tyrosine Kinase Inhibitor Therapy Prolongs Disease Control in EGFR-Mutant Advanced Lung Cancers with Acquired Resistance to EGFR Tyrosine Kinase Inhibitors: Two Case Reports

OBJECTIVE: Lung cancer remains the leading cause of malignant tumor-related death globally. There is mounting evidence that a large proportion of patients harboring epidermal growth factor receptor (EGFR) mutation and treated with EGFR TKI experience oligoprogressive disease. The optimal treatment s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Onco Targets Ther
Main Authors: Shi, Xuefei, Zhou, Jia, Qian, Caihua, Gao, Liliang, Wang, Bin, Feng, Xueren
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7369376/
https://ncbi.nlm.nih.gov/pubmed/32764966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S257431
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!